Ausgabe 1/2019
Inhalt (32 Artikel)
FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future
Abdullah Al-Zaghal, William Y. Raynor, Siavash Mehdizadeh Seraj, Thomas J. Werner, Abass Alavi
Value proposition of PSMA-targeted α–particle radioligand therapy in metastatic prostate cancer
Hossein Jadvar
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy
Andrea Farolfi, Francesco Ceci, Paolo Castellucci, Tiziano Graziani, Giambattista Siepe, Alessandro Lambertini, Riccardo Schiavina, Filippo Lodi, Alessio G. Morganti, Stefano Fanti
Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology
Peter Donato, Matthew J. Roberts, Andrew Morton, Samuel Kyle, Geoff Coughlin, Rachel Esler, Nigel Dunglison, Robert A. Gardiner, John Yaxley
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy
Francesco Ceci, Paolo Castellucci, Tiziano Graziani, Andrea Farolfi, Cristina Fonti, Filippo Lodi, Stefano Fanti
Salvage extended field or involved field nodal irradiation in 18F-fluorocholine PET/CT oligorecurrent nodal failures from prostate cancer
Alexis Lépinoy, Yannick E. Silva, Etienne Martin, Aurélie Bertaut, Magali Quivrin, Léone Aubignac, Alexandre Cochet, Gilles Créhange
Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human translation
Philippa Meershoek, Matthias N. van Oosterom, Hervé Simon, Laurent Mengus, Tobias Maurer, Pim J. van Leeuwen, Esther M. K. Wit, Henk G. van der Poel, Fijs W. B. van Leeuwen
Practice-based evidence for the clinical benefit of PET/CT—results of the first oncologic PET/CT registry in Germany
Christina Pfannenberg, Brigitte Gueckel, Lisa Wang, Sergios Gatidis, Susann-Cathrin Olthof, Werner Vach, Matthias Reimold, Christian la Fougere, Konstantin Nikolaou, Peter Martus
Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis
Coreline N. Burggraaff, Antoinette de Jong, Otto S. Hoekstra, Nikie J. Hoetjes, Rutger A. J. Nievelstein, Elise P. Jansma, Martijn W. Heymans, Henrica C. W. de Vet, Josée M. Zijlstra
Outcome of patients with early-stage follicular lymphoma staged with 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy alone
Sweet Ping Ng, Richard Khor, Mathias Bressel, Michael MacManus, John F Seymour, Rodney J. Hicks, Andrew Wirth
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma
Domenico Albano, Giovanni Bosio, Chiara Pagani, Alessandro Re, Alessandra Tucci, Raffaele Giubbini, Francesco Bertagna
FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial
Egesta Lopci, Maurizio Mascarin, Arnoldo Piccardo, Angelo Castello, Caterina Elia, Luca Guerra, Eugenio Borsatti, Alessandra Sala, Alessandra Todesco, Pietro Zucchetta, Piero Farruggia, Angelina Cistaro, Salvatore Buffardi, Patrizia Bertolini, Maurizio Bianchi, Maria Luisa Moleti, Feisal Bunkheila, Paolo Indolfi, Franca Fagioli, Alberto Garaventa, Roberta Burnelli
18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System
Sung-Hoon Jung, Seong Young Kwon, Jung-Joon Min, Hee-Seung Bom, Seo-Yeon Ahn, Seung-Yeon Jung, Seung-Shin Lee, Moo-Rim Park, Deok-Hwan Yang, Jae-Sook Ahn, Hyeoung-Joon Kim, Je-Jung Lee
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation
Daria Ripani, Carmelo Caldarella, Tommaso Za, Daniele Antonio Pizzuto, Elena Rossi, Valerio De Stefano, Alessandro Giordano
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, Florette Reyneke, Ismaheel Lawal, Thabo Lengana, Cindy Davis, Johncy Mahapane, Ceceila Corbett, Mariza Vorster, Alfred Morgenstern
Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT
Hendrik Rathke, Clemens Kratochwil, Ralph Hohenberger, Frederik Lars Giesel, Frank Bruchertseifer, Paul Flechsig, Alfred Morgenstern, Matti Hein, Peter Plinkert, Uwe Haberkorn, Olcay Cem Bulut
First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Jie Zang, Xinrong Fan, Hao Wang, Qingxing Liu, Jingnan Wang, Hui Li, Fang Li, Orit Jacobson, Gang Niu, Zhaohui Zhu, Xiaoyuan Chen
18F-FDGPET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study
Qian Wang, Ya-Ming Li, Yuan Li, Feng-Chun Hua, Quan-Shi Wang, Xiao-Li Zhang, Chao Cheng, Hua Wu, Zhi-Ming Yao, Wei-Fang Zhang, Qing-Yi Hou, Wei-Bing Miao, Xue-Mei Wang
FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging
A. P. Douglas, K. A. Thursky, L. J. Worth, E. Drummond, A. Hogg, R. J. Hicks, M. A. Slavin
Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections
Alfred O. Ankrah, Lambert F. R. Span, Hans C. Klein, Pim A. de Jong, Rudi A. J. O. Dierckx, Thomas C. Kwee, Mike M. Sathekge, Andor W. J. M. Glaudemans
Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study
Berit Dalsgaard Nielsen, Ib Tønder Hansen, Stine Kramer, Ate Haraldsen, Karin Hjorthaug, Trond Velde Bogsrud, June Anita Ejlersen, Lars Bjørn Stolle, Kresten Krarup Keller, Philip Therkildsen, Ellen-Margrethe Hauge, Lars Christian Gormsen
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study
Igor Diemberger, Rachele Bonfiglioli, Cristian Martignani, Maddalena Graziosi, Mauro Biffi, Stefano Lorenzetti, Matteo Ziacchi, Cristina Nanni, Stefano Fanti, Giuseppe Boriani
A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy
Pegah Jahangiri, Kamyar Pournazari, Drew A. Torigian, Thomas J. Werner, Samuel Swisher-McClure, Charles B. Simone II, Abass Alavi
Highlights from 2017: impactful topics published in the Annals of Nuclear Medicine
Andrea Farolfi, Pietro Ghedini, Stefano Fanti
Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements
Mahsa Eskian, Abass Alavi, MirHojjat Khorasanizadeh, Benjamin L. Viglianti, Hans Jacobsson, Tara D. Barwick, Alipasha Meysamie, Sun K. Yi, Shingo Iwano, Bohdan Bybel, Federico Caobelli, Filippo Lococo, Joaquim Gea, Antonio Sancho-Muñoz, Jukka Schildt, Ebru Tatcı, Constantin Lapa, Georgia Keramida, Michael Peters, Raef R. Boktor, Joemon John, Alexander G. Pitman, Tomasz Mazurek, Nima Rezaei
FDG PET/CT for assessing tumour response to immunotherapy
Nicolas Aide, Rodney J. Hicks, Christophe Le Tourneau, Stéphanie Lheureux, Stefano Fanti, Egesta Lopci
Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon
Jan Bucerius, Ingrid Dijkgraaf, Felix M. Mottaghy, Leon J. Schurgers
Correction to: Highlights from 2017: impactful topics published in the Annals of Nuclear Medicine
Andrea Farolfi, Pietro Ghedini, Stefano Fanti
Alan F. Weissman (Ed). Top Score for the Radiology Boards. Q&A for the Core and Certifying Exams
Luigi Mansi